Lv2
110 积分 2022-09-21 加入
Advances in head and neck pathology in China over the past ten years: retrospect and prospect
20天前
已完结
A cell line development strategy to improve a bispecific antibody expression purity in CHO cells
1个月前
已完结
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
2个月前
已完结
Controlled Fab-arm exchange for the generation of stable bispecific IgG1
4个月前
已完结
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
4个月前
已完结
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling
4个月前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
4个月前
已完结
Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices
5个月前
已完结
Oxytocin mediates early experience-dependent cross-modal plasticity in the sensory cortices
5个月前
已完结
Preclinical studies of the bispecific MUC1xEGFR antibody drug conjugate M1231 in EGFR mutant NSCLC
7个月前
已完结
皖公网安备34019202002308
